{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:48:45Z","timestamp":1786121325941,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.04.061","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:27:59Z","timestamp":1778023679000},"page":"4656-4669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Estrogen-mediated NF-\u03baB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy"],"prefix":"10.1016","volume":"34","author":[{"given":"M\u00e9lissa","family":"Viens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Geoffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elline","family":"Meuriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Buccilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Mullins-Dansereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Lou","family":"Myre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Paradisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Bardoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Mary","family":"Kalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Araripe","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Leclerc Desaulniers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy-Dung","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Cameron","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vanderhyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Alain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic Guy","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Parker","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-2235","authenticated-orcid":false,"given":"Marie-Claude","family":"Bourgeois-Daigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.04.061_bib1","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.04.061_bib2","series-title":"Breast Cancer","article-title":"Subtypes of Breast Cancer","author":"Orrantia-Borunda","year":"2022"},{"key":"10.1016\/j.ymthe.2026.04.061_bib3","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms24076834","article-title":"A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.04.061_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4331\/wjbc.v6.i3.231","article-title":"Current medical treatment of estrogen receptor-positive breast cancer","volume":"6","author":"Lumachi","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.04.061_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: Pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ymthe.2026.04.061_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216634","article-title":"Oncolytic virus-based combination therapy in breast cancer","volume":"585","author":"Bahreyni","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.04.061_bib7","doi-asserted-by":"crossref","first-page":"e1655363","DOI":"10.1080\/2162402X.2019.1655363","article-title":"Pre-surgical oncolytic virotherapy improves breast cancer outcomes","volume":"8","author":"Mullins-Dansereau","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ymthe.2026.04.061_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ebiom.2016.06.046","article-title":"Oncolytic Viruses: Therapeutics With an Identity Crisis","volume":"9","author":"Breitbach","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2026.04.061_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13058-016-0744-y","article-title":"Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment","volume":"18","author":"Bourgeois-Daigneault","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymthe.2026.04.061_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao1641","article-title":"Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy","volume":"10","author":"Bourgeois-Daigneault","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.061_bib11","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41598-018-38385-7","article-title":"Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer","volume":"9","author":"Martin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.04.061_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.04.061_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.04.061_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cytogfr.2010.02.014","article-title":"Impact of tumor microenvironment on oncolytic viral therapy","volume":"21","author":"Wojton","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymthe.2026.04.061_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ccell.2015.06.009","article-title":"VEGF-Mediated Induction of PRD1-BF1\/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection","volume":"28","author":"Arulanandam","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.04.061_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nm.3848","article-title":"Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity","volume":"21","author":"Ilkow","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.04.061_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/clinchem\/hvaf039","article-title":"A Comprehensive Review of Estradiol, Progesterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in the Context of Laboratory Medicine to Support Women\u2019s Health","volume":"71","author":"Greene","year":"2025","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymthe.2026.04.061_bib18","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.bbamcr.2014.08.004","article-title":"The intricate interplay between RNA viruses and NF-\u03baB","volume":"1843","author":"Schmitz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2026.04.061_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106966","article-title":"NF-\u03baB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.04.061_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.stem.2016.05.003","article-title":"Persistent Activation of NF-\u03baB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage","volume":"19","author":"Sau","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.04.061_bib21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/ncomms3299","article-title":"NF-\u03baB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype","volume":"4","author":"Yamamoto","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.061_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/0929867321666141106124315","article-title":"Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy","volume":"22","author":"Wang","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymthe.2026.04.061_bib23","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.3390\/cancers14215215","article-title":"Inhibition of I\u03baB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells","volume":"14","author":"Yi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2026.04.061_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","article-title":"Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta","volume":"119","author":"Weber","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2026.04.061_bib25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2165\/00003495-200565130-00008","article-title":"Sulfasalazine: a review of its use in the management of rheumatoid arthritis","volume":"65","author":"Plosker","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2026.04.061_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.1","article-title":"Oncolytic vesicular stomatitis virus expressing interferon-\u03b3 has enhanced therapeutic activity","volume":"3","author":"Bourgeois-Daigneault","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2026.04.061_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2015.10.030","article-title":"Programmable insect cell carriers for systemic delivery of integrated cancer biotherapy","volume":"220","author":"Roy","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.04.061_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40425-018-0366-2","article-title":"Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference","volume":"6","author":"Bastin","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.04.061_bib29","article-title":"Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer","volume":"32","author":"Geoffroy","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.ymthe.2026.04.061_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1039\/C8LC00982A","article-title":"Paraffin-embedding lithography and micro-dissected tissue micro-arrays: tools for biological and pharmacological analysis of ex vivo solid tumors","volume":"19","author":"Simeone","year":"2019","journal-title":"Lab. Chip"},{"key":"10.1016\/j.ymthe.2026.04.061_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0022-4731(89)90239-2","article-title":"Phenol red mimics biological actions of estradiol: Enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo","volume":"33","author":"Ernst","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.ymthe.2026.04.061_bib32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10616-015-9844-2","article-title":"Estrogen and phenol red free medium for osteoblast culture: study of the mineralization ability","volume":"68","author":"de Faria","year":"2016","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ymthe.2026.04.061_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cells14100703","article-title":"17\u03b2-Estradiol Promotes Tumorigenicity Through an Autocrine AREG\/EGFR Loop in ER-\u03b1-Positive Breast Cancer Cells","volume":"14","author":"Yoon","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.04.061_bib34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41388-025-03357-5","article-title":"Deciphering permissivity of human tumor ecosystems to oncolytic viruses","volume":"44","author":"Schoeps","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2026.04.061_bib35","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1210\/en.2006-0563","article-title":"Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells","volume":"147","author":"Chang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymthe.2026.04.061_bib36","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO\/CAP Guideline Update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.04.061_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1634\/theoncologist.7-2-163","article-title":"The molecular perspective: tamoxifen and the estrogen receptor","volume":"7","author":"Goodsell","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.ymthe.2026.04.061_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/cr.2018.15","article-title":"Tamoxifen enhances stemness and promotes metastasis of ER\u03b136+ breast cancer by upregulating ALDH1A1 in cancer cells","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2026.04.061_bib39","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.04.061_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.061_bib41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/mt.2010.67","article-title":"A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers","volume":"18","author":"Diallo","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.061_bib42","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3892\/or.2012.1642","article-title":"MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion","volume":"27","author":"PARK","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ymthe.2026.04.061_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1593\/tlo.08133","article-title":"Proteasome Inhibitor MG132 Induces Apoptosis and Inhibits Invasion of Human Malignant Pleural Mesothelioma Cells","volume":"1","author":"Yuan","year":"2008","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ymthe.2026.04.061_bib44","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.chembiol.2015.10.011","article-title":"Reciprocal Regulation of ER\u03b1 and ER\u03b2 Stability and Activity by Diptoindonesin G","volume":"22","author":"Zhao","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.04.061_bib45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","article-title":"Estrogen receptor alpha and beta in health and disease","volume":"29","author":"Jia","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2026.04.061_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejca.2018.03.014","article-title":"Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer","volume":"95","author":"Blok","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.04.061_bib47","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jcb.22141","article-title":"NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells","volume":"107","author":"Gionet","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2026.04.061_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036890","article-title":"Estrogen Modulates NF\u03baB Signaling by Enhancing I\u03baB\u03b1 Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-\u03b2","volume":"7","author":"Xing","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.04.061_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao1613","article-title":"Dimethyl fumarate potentiates oncolytic virotherapy through NF-\u03baB inhibition","volume":"10","author":"Selman","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.061_bib50","doi-asserted-by":"crossref","first-page":"R369","DOI":"10.1530\/ERC-19-0087","article-title":"The NF-KB pathway and endocrine therapy resistance in breast cancer","volume":"26","author":"Khongthong","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2026.04.061_bib51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","article-title":"Non-obese diabetic\u2013recombination activating gene-1 (NOD\u2013Rag 1 null) interleukin (IL)-2 receptor common gamma chain (IL 2 r\u03b3null) null mice: a radioresistant model for human lymphohaematopoietic engraftment","volume":"154","author":"Pearson","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.061_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-28940-2","article-title":"Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers","volume":"13","author":"Geoffroy","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.04.061_bib53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.04.061_bib54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","article-title":"Differential analysis of RNA-seq incorporating quantification uncertainty","volume":"14","author":"Pimentel","year":"2017","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:10:27Z","timestamp":1786075827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1525001626003825"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.061","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen-mediated NF-\u03baB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}